<DOC>
	<DOC>NCT00311974</DOC>
	<brief_summary>We, the investigators at Holstebro Hospital, want to test the hypothesis that dihydralazine leads to the activation of the sympathetic nervous system in healthy individuals.</brief_summary>
	<brief_title>The Effect of Dihydralazine on Kidney Function and Hormones in Healthy Individuals</brief_title>
	<detailed_description />
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Dihydralazine</mesh_term>
	<criteria>1. Men 2. Ages 18 to 40 years. 3. Body mass index less than or equal to 30 kg/m2 1. History or clinical signs of heart, lung, kidney, or endocrine organ disease. 2. Abnormal biochemical screening of the blood regarding: Bhemoglobin, Psodium, Ppotassium, Pcreatinine, Palbumin, Pbilirubin, Palanine aminotransferase, Palkaline phosphatase, Pcholesterol, and Bglucose. 3. Abnormal screening of the urine regarding: albumin and glucose 4. Malignant disease. 5. Known arterial hypertension or measured 24 hour blood pressure above 135 mmHg systolic or 85 mmHg diastolic. 6. Alcohol abuse. 7. Smoking. 8. Drug use or abuse. 9. Known intolerance or allergy to dihydralazine 10. Blood donation within 1 month of the start of the study.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Dihydralazine</keyword>
	<keyword>Sympathetic activation</keyword>
	<keyword>Fractional sodium excretion</keyword>
</DOC>